Regulatory Framework for Approval of New Animal Drugs in United States

Rajashree Patil, Chandrakant Galdhar


Animal healthcare is a booming market catering needs of several companion and production purpose animals. Animal drug approval process in the United States (US) involves submission of an Investigational New Animal Drug Application (INAD), followed by submission of New Animal Drug Application (NADA) to the Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM). Although regional variations are present in the regulatory process for veterinary healthcare products across the globe, harmonization initiatives like International Cooperation on Harmonization of Technical Requirements for the Registration of Veterinary Medicinal Products (VICH) are playing a vital role in the veterinary medicinal product registration process by availing detailed guidance documents. The current article focuses on the regulatory requirements for new animal drug registration in the US.


US FDA; CVM; new animal drug approval; INAD; NADA

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

*2016 Journal Impact Factor was established by dividing the number of articles published in 2014 and 2015 with the number of times they are cited in 2016 based on Google Scholar, Google Search and the Microsoft Academic Search. If ‘A’ is the total number of articles published in 2014 and 2015, and ‘B’ is the number of times these articles were cited in indexed publications during 2016 then, journal impact factor = A/B. To know More: (